Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Oxytetracycline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.70 |
| ▸ | MEN1 | O00255 | 9/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.70 |
| ▸ | USP2 | O75604 | 7/20 | 0.70 |
| ▸ | HPGD | P15428 | 6/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.70 |
| ▸ | RECQL | P46063 | 5/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | THRB | P10828 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxytetracycline SCHEMBL20740448 | 1.00 | TDP1 (0.70) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL20740451 | 1.00 | TDP1 (0.70) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL2898 | 1.00 | TDP1 (0.70) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL22769463 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL11331676 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL21409869 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL3954956 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL10765981 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL459700 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 | |
| Oxytetracycline SCHEMBL2806490 | 0.99 | TDP1 (0.69) | TDP1MEN1KMT2AKDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110693826-A | Long-acting oxytetracycline injection for livestock and preparation method thereof | 成都新亨药业有限公司 | 2020-01-17 | — | — | CN | claimed |
| EP-2351570-A1 | An Antibiotic/Analgesic Formulation And a Method of Making This Formulation | IVX Animal Health, Inc. (US) | 2011-08-03 | — | — | EP | claimed |
| EP-1345611-A4 | AN ANTIBIOTIC/ANALGESIC FORMULATION AND A METHOD OF MAKING THIS FORMULATION | PHOENIX SCIENT INC (US) | 2005-11-16 | — | — | EP | claimed |
| EP-1345611-A1 | AN ANTIBIOTIC/ANALGESIC FORMULATION AND A METHOD OF MAKING THIS FORMULATION | Phoenix Scientific, Inc. (US) | 2003-09-24 | — | — | EP | claimed |
| WO-2002041899-A1 | AN ANTIBIOTIC/ANALGESIC FORMULATION AND A METHOD OF MAKING THIS FORMULATION | PHOENIX SCIENTIFIC, INC. (US) | 2002-05-30 | — | — | WO | claimed |
| EP-0634995-B1 | PROCESS AND INTERMEDIATE FOR THE PURIFICATION OF OXYTETRACYCLINE | PLIVA HANDELS GMBH (DE) | 1996-07-03 | — | — | EP | claimed |
| US-5387703-A | Process and intermediate for the purification of oxytetracycline | PLIVA (HR) | 1995-02-07 | — | — | US | claimed |
| EP-0634995-A1 | PROCESS AND INTERMEDIATE FOR THE PURIFICATION OF OXYTETRACYCLINE. | PLIVA HANDELS GMBH (DE) | 1995-01-25 | — | — | EP | claimed |
| WO-1993020042-A1 | PROCESS AND INTERMEDIATE FOR THE PURIFICATION OF OXYTETRACYCLINE | PLIVA HANDELS GMBH (DE) | 1993-10-14 | — | — | WO | claimed |
| US-4772460-A | INJECTING AQUEOUS SOLUTION CONTAINING N-METHYL PYRROLIDONE AND MAGNESIUM COMPOUND | BIMEDA RESEARCH AND DEVELOPMENT, LTD. (IE) | 1988-09-20 | — | — | US | claimed |
| EP-4727359-A1 | FUNGICIDAL COMPOSITIONS | Syngenta Crop Protection AG (CH) | 2026-04-22 | — | — | EP | disclosed |
| WO-2026047037-A1 | MICROBIOCIDAL QUINOLINE-AMIDE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2026-03-05 | — | — | WO | disclosed |
| WO-2025233384-A1 | MICROBIOCIDAL PYRAZOLE COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025202482-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2025-10-02 | — | — | WO | disclosed |
| WO-2025202499-A1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2025-10-02 | — | — | WO | disclosed |
| US-4772460-A | INJECTING AQUEOUS SOLUTION CONTAINING N-METHYL PYRROLIDONE AND MAGNESIUM COMPOUND | BIMEDA RESEARCH AND DEVELOPMENT, LTD. (IE) | 1988-09-20 | — | — | US | disclosed |
| EP-0096942-B1 | OXYTETRACYCLINE COMPOSITION AND PROCESS FOR PREPARING AN OXYTETRACYCLINE COMPOSITION | Aesculaap B.V. (NL) | 1986-03-19 | — | — | EP | disclosed |
| EP-0096942-A2 | Oxytetracycline composition and process for preparing an oxytetracycline composition | Aesculaap B.V. (NL) | 1983-12-28 | — | — | EP | disclosed |
| US-4219545-A | ADMINISTERING RIBOFLAVIN | COLLINS CALVIN E | 1980-08-26 | — | — | US | disclosed |
| US-3987797-A | ANTIMICROBIAL SUTURES | ETHICON, INC. (US) | 1976-10-26 | — | — | US | disclosed |